| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United Kingdom | 67 | |
| #2 | WIPO (World Intellectual Property Organization) | 47 | |
| #3 | EPO (European Patent Office) | 36 | |
| #4 | China | 27 | |
| #5 | Canada | 24 | |
| #6 | Mexico | 20 | |
| #7 | United States | 20 | |
| #8 | Brazil | 19 | |
| #9 | Australia | 13 | |
| #10 | Republic of Korea | 12 | |
| #11 | Japan | 7 | |
| #12 | Israel | 6 | |
| #13 | New Zealand | 6 | |
| #14 | Norway | 5 | |
| #15 | Czechia | 4 | |
| #16 | Poland | 4 | |
| #17 | Yugoslavia (Serbia and Montenegro) | 4 | |
| #18 | Hong Kong | 3 | |
| #19 | Hungary | 3 | |
| #20 | South Africa | 3 | |
| #21 | Costa Rica | 2 | |
| #22 | Indonesia | 2 | |
| #23 | Nicaragua | 2 | |
| #24 | Ukraine | 2 | |
| #25 | Argentina | 1 | |
| #26 | Bulgaria | 1 | |
| #27 | EAPO (Eurasian Patent Organization) | 1 | |
| #28 | Ecuador | 1 | |
| #29 | Estonia | 1 | |
| #30 | Iceland | 1 | |
| #31 | African Intellectual Property Organization | 1 | |
| #32 | Slovakia | 1 | |
| #33 | Uruguay | 1 |
| # | Industry | |
|---|---|---|
| #1 | Biotechnology | |
| #2 | Organic fine chemistry | |
| #3 | Pharmaceuticals | |
| #4 | Machines | |
| #5 | Environmental technology | |
| #6 | Measurement |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Heterocyclic compounds | |
| #3 | Fermentation | |
| #4 | Microorganisms | |
| #5 | Peptides | |
| #6 | Sugars | |
| #7 | Medical preparations | |
| #8 | Unspecified technologies | |
| #9 | Climate change adaptation technologies | |
| #10 | Analysing materials |
| # | Name | Total Patents |
|---|---|---|
| #1 | Leadlay Peter Francis | 81 |
| #2 | Wilkinson Barrie | 72 |
| #3 | Staunton James | 69 |
| #4 | Moss Steven | 53 |
| #5 | Gaisser Sabine | 53 |
| #6 | Gregory Matthew Alan | 50 |
| #7 | Cortes Jesus | 49 |
| #8 | Sheridan Rose Mary | 43 |
| #9 | Mcarthur Hamish Alastair Irvin | 38 |
| #10 | Martin Christine | 36 |
| Publication | Filing date | Title |
|---|---|---|
| GB201202060D0 | Novel compounds and methods for their production | |
| GB201122305D0 | Novel compound | |
| GB201118334D0 | Novel dosage form | |
| GB201113626D0 | Novel compounds and methods for their production | |
| GB201113629D0 | Novel compounds and methods for their production | |
| GB201105293D0 | Novel compounds and methods for their production | |
| WO2011098805A1 | Sanglifehrin based compounds | |
| WO2011098808A1 | Sanglifehrin based compounds | |
| CN102770139A | Sanglifehrin based compounds | |
| GB201101085D0 | Novel compounds | |
| GB201021522D0 | Novel compounds and methods for their production | |
| GB201008123D0 | Novel compounds | |
| GB201006124D0 | Novel compounds | |
| GB201006126D0 | Novel compounds | |
| GB201006128D0 | Novel compounds | |
| GB201002094D0 | Novel compounds | |
| GB201002097D0 | Novel compounds | |
| GB201002096D0 | Novel compounds | |
| GB0917816D0 | Novel compounds and methods for their production | |
| GB0917817D0 | Novel compounds and methods for their production |